Cargando…
Inhaled Nitric Oxide Therapy Fails to Improve Outcome in Experimental Severe Influenza
In vitro, nitric oxide (NO) has been shown to have antimicrobial activity against a wide range of viruses, including influenza A virus. Therefore, we hypothesized that inhaled nitric oxide (iNO) would increase survival in vivo by reducing the viral load in C57Bl/6 mice infected with a lethal dose of...
Autores principales: | Darwish, Ilyse, Miller, Chris, Kain, Kevin C., Liles, W. Conrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258558/ https://www.ncbi.nlm.nih.gov/pubmed/22253563 http://dx.doi.org/10.7150/ijms.3880 |
Ejemplares similares
-
Mesenchymal Stromal (Stem) Cell Therapy Fails to Improve Outcomes in Experimental Severe Influenza
por: Darwish, Ilyse, et al.
Publicado: (2013) -
Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome
por: Kim, Hani, et al.
Publicado: (2014) -
Inhaled Nitric Oxide Reduces Endothelial Activation and Parasite Accumulation in the Brain, and Enhances Survival in Experimental Cerebral Malaria
por: Serghides, Lena, et al.
Publicado: (2011) -
Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial
por: Hawkes, Michael T., et al.
Publicado: (2015) -
Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
por: Hawkes, Michael, et al.
Publicado: (2011)